Gail M Farfel
CIK 1614780 · Chief Executive Officer · last filed 2025-09-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$571.2K
Companies
5
Total Filings
41
Lifetime Open-Market Net
-$1.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DURECT CORP (DRRX) Delisted | Director | 0 | $1.91 | $0 | $39.8K | 12 | 2025-09-12 |
| PMN | Chief Executive Officer | 55,192 | $10.35 | $571.2K | $10.6K | 4 | 2023-08-25 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | — | $16.80 | — | $0 | 4 | 2023-06-08 |
| ZOGENIX, INC. (ZGNX) Delisted | EVP/Chief Development Officer | 13,818 | $26.68 | $368.7K | -$1.48M | 18 | 2021-03-30 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Chief Clinical Dev & Reg Offic | 30,000 | $0.55 | $16.5K | -$284.5K | 2 | 2015-04-23 |
Recent Filings · Page 4 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-09 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | — | -$203.8K | EDGAR |
| 2018-09-05 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | — | -$235.3K | EDGAR |
| 2018-08-10 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | — | -$270.6K | EDGAR |
| 2018-06-13 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | −118 | -$160.5K | EDGAR |
| 2018-03-16 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-16 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-16 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-07 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-06 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-23 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | — | -$253.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.